Review





Similar Products

94
Multi Sciences (Lianke) Biotech Co Ltd pe cy7 anti mouse ifn γ
Pe Cy7 Anti Mouse Ifn γ, supplied by Multi Sciences (Lianke) Biotech Co Ltd, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti%E2%80%93mouse+ifn-%CE%B3+antibody/Anti-Mouse+IFN-%CE%B3/pm42378778-104-19-29
Average 94 stars, based on 1 article reviews
pe cy7 anti mouse ifn γ - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

94
MedChemExpress anti ifn treatments mice
Anti Ifn Treatments Mice, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti%E2%80%93mouse+ifn-%CE%B3+antibody/Anti-Mouse+IFN+gamma+Antibody/pm42174265-415-3-16
Average 94 stars, based on 1 article reviews
anti ifn treatments mice - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

95
Bio X Cell anti ifn γ
Anti Ifn γ, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti%E2%80%93mouse+ifn-%CE%B3+antibody/InVivoMAb+anti-mouse+IFN%CE%B3/pm42841663-95-7-8
Average 95 stars, based on 1 article reviews
anti ifn γ - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

92
Biogems International anti ifn γ
Anti Ifn γ, supplied by Biogems International, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti%E2%80%93mouse+ifn-%CE%B3+antibody/Anti-Mouse+IFN+gamma+SAFIRE+Purified/pm42601006-93-44-49
Average 92 stars, based on 1 article reviews
anti ifn γ - by Bioz Stars, 2026-11
92/100 stars
  Buy from Supplier

95
Bio X Cell ifn γ
( A ) Western blotting analysis of the indicated proteins in WT (WT), IKKε single knockout (KO), TBK1 single knockout, and double knockout (DKO) B16-F1 melanoma cells generated by CRISPR. ( B ) Control sgRNA (WT), IKKε and TBK1 single KO, and DKO B16 cell lines were stimulated in triplicate with medium alone, TNF (100 ng/ml), or <t>IFN-γ</t> (100 ng/ml) and imaged for 48 hours in an IncuCyte S3 in the presence of YOYO-3 to measure cell death. The confluency of the cells in each well was also quantified. Data is presented as YOYO-3 counts normalized to confluency in each well. Values are means ± SD of triplicate samples. ( C ) WT and DKO B16 cells were treated with IFN-γ (100 ng/ml) in the presence of DMSO or 10 μM Nec-1s and analyzed in an IncuCyte to measure cell death. Values are means ± SD of triplicate samples. ( D ) Western blotting analysis of the indicated proteins in WT and DKO B16 cells pretreated with 20 μM zVAD-fmk for 30 min, followed by treatment with IFN-γ (100 ng/ml) for the indicated times. Blot shown is representative of three that were performed. Bar chart indicates signal intensity of pRIPK1 relative to total RIPK1 for each lane from the three experiments with each experiment coded in a different color. Values are means ± SD of the three biological replicates. ** p <0.01 by one-way ANOVA with Sidak’s multiple comparison test. ( E ) Western blotting analysis of the indicated proteins in WT and DKO B16 cells treated for 24 hours with the indicated concentrations (ng/ml) of IFN-γ. Blot shown is representative of three that were performed. Bar chart indicates signal intensity of cleaved CASP8 and CASP3 relative to actin from the three experiments with each experiment coded in a different color. Values are means ± SD of the three biological replicates. ** p <0.01, *** p <0.001 and **** p <0.0001 by two-way ANOVA with Sidak’s multiple comparison test. ( F and G ) WT, DKO, TBK1/IKKε/FADD TKO (F), and TBK1/IKKε/CASP8 TKO (G) B16 cells were treated with IFN-γ (100 ng/ml) and analyzed in an IncuCyte to measure cell death. Values are means ± SD of triplicate samples. In (B) to (C) and (F) to (G), n = 3 technical replicates per group and data are representative of at least three independent experiments.
Ifn γ, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti%E2%80%93mouse+ifn-%CE%B3+antibody/InVivoMAb+anti-mouse+IFN%CE%B3/pmc13674687-603-16-19
Average 95 stars, based on 1 article reviews
ifn γ - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

86
Mabtech Inc anti mouse ifn γ capture antibody
( A ) Western blotting analysis of the indicated proteins in WT (WT), IKKε single knockout (KO), TBK1 single knockout, and double knockout (DKO) B16-F1 melanoma cells generated by CRISPR. ( B ) Control sgRNA (WT), IKKε and TBK1 single KO, and DKO B16 cell lines were stimulated in triplicate with medium alone, TNF (100 ng/ml), or <t>IFN-γ</t> (100 ng/ml) and imaged for 48 hours in an IncuCyte S3 in the presence of YOYO-3 to measure cell death. The confluency of the cells in each well was also quantified. Data is presented as YOYO-3 counts normalized to confluency in each well. Values are means ± SD of triplicate samples. ( C ) WT and DKO B16 cells were treated with IFN-γ (100 ng/ml) in the presence of DMSO or 10 μM Nec-1s and analyzed in an IncuCyte to measure cell death. Values are means ± SD of triplicate samples. ( D ) Western blotting analysis of the indicated proteins in WT and DKO B16 cells pretreated with 20 μM zVAD-fmk for 30 min, followed by treatment with IFN-γ (100 ng/ml) for the indicated times. Blot shown is representative of three that were performed. Bar chart indicates signal intensity of pRIPK1 relative to total RIPK1 for each lane from the three experiments with each experiment coded in a different color. Values are means ± SD of the three biological replicates. ** p <0.01 by one-way ANOVA with Sidak’s multiple comparison test. ( E ) Western blotting analysis of the indicated proteins in WT and DKO B16 cells treated for 24 hours with the indicated concentrations (ng/ml) of IFN-γ. Blot shown is representative of three that were performed. Bar chart indicates signal intensity of cleaved CASP8 and CASP3 relative to actin from the three experiments with each experiment coded in a different color. Values are means ± SD of the three biological replicates. ** p <0.01, *** p <0.001 and **** p <0.0001 by two-way ANOVA with Sidak’s multiple comparison test. ( F and G ) WT, DKO, TBK1/IKKε/FADD TKO (F), and TBK1/IKKε/CASP8 TKO (G) B16 cells were treated with IFN-γ (100 ng/ml) and analyzed in an IncuCyte to measure cell death. Values are means ± SD of triplicate samples. In (B) to (C) and (F) to (G), n = 3 technical replicates per group and data are representative of at least three independent experiments.
Anti Mouse Ifn γ Capture Antibody, supplied by Mabtech Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti%E2%80%93mouse+ifn-%CE%B3+antibody/anti+capture/bio_rxiv__64898__2026__05__13__723724-224-9-16
Average 86 stars, based on 1 article reviews
anti mouse ifn γ capture antibody - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

86
Mabtech Inc biotinylated anti mouse ifn γ detection antibody
( A ) Western blotting analysis of the indicated proteins in WT (WT), IKKε single knockout (KO), TBK1 single knockout, and double knockout (DKO) B16-F1 melanoma cells generated by CRISPR. ( B ) Control sgRNA (WT), IKKε and TBK1 single KO, and DKO B16 cell lines were stimulated in triplicate with medium alone, TNF (100 ng/ml), or <t>IFN-γ</t> (100 ng/ml) and imaged for 48 hours in an IncuCyte S3 in the presence of YOYO-3 to measure cell death. The confluency of the cells in each well was also quantified. Data is presented as YOYO-3 counts normalized to confluency in each well. Values are means ± SD of triplicate samples. ( C ) WT and DKO B16 cells were treated with IFN-γ (100 ng/ml) in the presence of DMSO or 10 μM Nec-1s and analyzed in an IncuCyte to measure cell death. Values are means ± SD of triplicate samples. ( D ) Western blotting analysis of the indicated proteins in WT and DKO B16 cells pretreated with 20 μM zVAD-fmk for 30 min, followed by treatment with IFN-γ (100 ng/ml) for the indicated times. Blot shown is representative of three that were performed. Bar chart indicates signal intensity of pRIPK1 relative to total RIPK1 for each lane from the three experiments with each experiment coded in a different color. Values are means ± SD of the three biological replicates. ** p <0.01 by one-way ANOVA with Sidak’s multiple comparison test. ( E ) Western blotting analysis of the indicated proteins in WT and DKO B16 cells treated for 24 hours with the indicated concentrations (ng/ml) of IFN-γ. Blot shown is representative of three that were performed. Bar chart indicates signal intensity of cleaved CASP8 and CASP3 relative to actin from the three experiments with each experiment coded in a different color. Values are means ± SD of the three biological replicates. ** p <0.01, *** p <0.001 and **** p <0.0001 by two-way ANOVA with Sidak’s multiple comparison test. ( F and G ) WT, DKO, TBK1/IKKε/FADD TKO (F), and TBK1/IKKε/CASP8 TKO (G) B16 cells were treated with IFN-γ (100 ng/ml) and analyzed in an IncuCyte to measure cell death. Values are means ± SD of triplicate samples. In (B) to (C) and (F) to (G), n = 3 technical replicates per group and data are representative of at least three independent experiments.
Biotinylated Anti Mouse Ifn γ Detection Antibody, supplied by Mabtech Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti%E2%80%93mouse+ifn-%CE%B3+antibody/anti+biotinylated+detection+ifn+mouse+%CE%B3/bio_rxiv__64898__2026__05__13__723724-228-6-12
Average 86 stars, based on 1 article reviews
biotinylated anti mouse ifn γ detection antibody - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

Image Search Results


( A ) Western blotting analysis of the indicated proteins in WT (WT), IKKε single knockout (KO), TBK1 single knockout, and double knockout (DKO) B16-F1 melanoma cells generated by CRISPR. ( B ) Control sgRNA (WT), IKKε and TBK1 single KO, and DKO B16 cell lines were stimulated in triplicate with medium alone, TNF (100 ng/ml), or IFN-γ (100 ng/ml) and imaged for 48 hours in an IncuCyte S3 in the presence of YOYO-3 to measure cell death. The confluency of the cells in each well was also quantified. Data is presented as YOYO-3 counts normalized to confluency in each well. Values are means ± SD of triplicate samples. ( C ) WT and DKO B16 cells were treated with IFN-γ (100 ng/ml) in the presence of DMSO or 10 μM Nec-1s and analyzed in an IncuCyte to measure cell death. Values are means ± SD of triplicate samples. ( D ) Western blotting analysis of the indicated proteins in WT and DKO B16 cells pretreated with 20 μM zVAD-fmk for 30 min, followed by treatment with IFN-γ (100 ng/ml) for the indicated times. Blot shown is representative of three that were performed. Bar chart indicates signal intensity of pRIPK1 relative to total RIPK1 for each lane from the three experiments with each experiment coded in a different color. Values are means ± SD of the three biological replicates. ** p <0.01 by one-way ANOVA with Sidak’s multiple comparison test. ( E ) Western blotting analysis of the indicated proteins in WT and DKO B16 cells treated for 24 hours with the indicated concentrations (ng/ml) of IFN-γ. Blot shown is representative of three that were performed. Bar chart indicates signal intensity of cleaved CASP8 and CASP3 relative to actin from the three experiments with each experiment coded in a different color. Values are means ± SD of the three biological replicates. ** p <0.01, *** p <0.001 and **** p <0.0001 by two-way ANOVA with Sidak’s multiple comparison test. ( F and G ) WT, DKO, TBK1/IKKε/FADD TKO (F), and TBK1/IKKε/CASP8 TKO (G) B16 cells were treated with IFN-γ (100 ng/ml) and analyzed in an IncuCyte to measure cell death. Values are means ± SD of triplicate samples. In (B) to (C) and (F) to (G), n = 3 technical replicates per group and data are representative of at least three independent experiments.

Journal: Science signaling

Article Title: Loss of the kinases TBK1 and IKKε sensitizes target cancer cells to T cell killing through an IFN-γ–mediated inflammatory death program

doi: 10.1126/scisignal.adz7366

Figure Lengend Snippet: ( A ) Western blotting analysis of the indicated proteins in WT (WT), IKKε single knockout (KO), TBK1 single knockout, and double knockout (DKO) B16-F1 melanoma cells generated by CRISPR. ( B ) Control sgRNA (WT), IKKε and TBK1 single KO, and DKO B16 cell lines were stimulated in triplicate with medium alone, TNF (100 ng/ml), or IFN-γ (100 ng/ml) and imaged for 48 hours in an IncuCyte S3 in the presence of YOYO-3 to measure cell death. The confluency of the cells in each well was also quantified. Data is presented as YOYO-3 counts normalized to confluency in each well. Values are means ± SD of triplicate samples. ( C ) WT and DKO B16 cells were treated with IFN-γ (100 ng/ml) in the presence of DMSO or 10 μM Nec-1s and analyzed in an IncuCyte to measure cell death. Values are means ± SD of triplicate samples. ( D ) Western blotting analysis of the indicated proteins in WT and DKO B16 cells pretreated with 20 μM zVAD-fmk for 30 min, followed by treatment with IFN-γ (100 ng/ml) for the indicated times. Blot shown is representative of three that were performed. Bar chart indicates signal intensity of pRIPK1 relative to total RIPK1 for each lane from the three experiments with each experiment coded in a different color. Values are means ± SD of the three biological replicates. ** p <0.01 by one-way ANOVA with Sidak’s multiple comparison test. ( E ) Western blotting analysis of the indicated proteins in WT and DKO B16 cells treated for 24 hours with the indicated concentrations (ng/ml) of IFN-γ. Blot shown is representative of three that were performed. Bar chart indicates signal intensity of cleaved CASP8 and CASP3 relative to actin from the three experiments with each experiment coded in a different color. Values are means ± SD of the three biological replicates. ** p <0.01, *** p <0.001 and **** p <0.0001 by two-way ANOVA with Sidak’s multiple comparison test. ( F and G ) WT, DKO, TBK1/IKKε/FADD TKO (F), and TBK1/IKKε/CASP8 TKO (G) B16 cells were treated with IFN-γ (100 ng/ml) and analyzed in an IncuCyte to measure cell death. Values are means ± SD of triplicate samples. In (B) to (C) and (F) to (G), n = 3 technical replicates per group and data are representative of at least three independent experiments.

Article Snippet: Antagonist antibodies used were from the following sources: TNF (clone XT3.11, Bio X Cell BE0058) and IFN-γ (clone XMG1.2, Bio X Cell BE0055).

Techniques: Western Blot, Analysis, Knock-Out, Double Knockout, Generated, CRISPR, Control, Comparison

( A ) WT and DKO B16 cells were pulsed with control LCMV GP33 peptide or OVA SIINFEKL peptide followed by co-culture with either control medium (left) or OT-I T cells at 1:4 effector to target (E/T) ratio (right). Target cell death was analyzed by IncuCyte. Values are means ± SD of triplicate samples. ( B and C ) WT, DKO, TBK1/IKKε/CASP8 TKO (B), and TBK1/IKKε/FADD TKO (C) B16 cells were pulsed with OVA peptide followed by co-culture with OT-I T cells at a 1:4 E/T ratio. Target cell death was analyzed by IncuCyte. Values are means ± SD of triplicate samples. ( D ) DKO B16 cells were pulsed with OVA peptide followed by co-culture with OT-I T cells at a 1:4 E/T ratio and treated with control IgG (50 μg/ml), anti-TNF (50 μg/ml), anti–IFN-γ (50 μg/ml), or both mAbs (50 μg/ml). Target cell death was analyzed by IncuCyte. Values are means ± SD of triplicate samples. ( E ) Tumor volume analysis of NSG mice bearing B16 WT- or DKO-cOVA tumors treated i.v. once on day 12 after tumor implant with PBS or OT-I T cells (1 x 10 6 cells in 100 μl); WT (PBS): n = 13 mice; DKO (PBS): n = 11 mice; WT (OT-I): n = 7 mice; DKO (OT-I): n = 8 mice. Values are means ± SEM. * P < 0.05 by unpaired t test. In (A) to (D), n = 3 technical replicates per group, and data are representative of at least three independent experiments.

Journal: Science signaling

Article Title: Loss of the kinases TBK1 and IKKε sensitizes target cancer cells to T cell killing through an IFN-γ–mediated inflammatory death program

doi: 10.1126/scisignal.adz7366

Figure Lengend Snippet: ( A ) WT and DKO B16 cells were pulsed with control LCMV GP33 peptide or OVA SIINFEKL peptide followed by co-culture with either control medium (left) or OT-I T cells at 1:4 effector to target (E/T) ratio (right). Target cell death was analyzed by IncuCyte. Values are means ± SD of triplicate samples. ( B and C ) WT, DKO, TBK1/IKKε/CASP8 TKO (B), and TBK1/IKKε/FADD TKO (C) B16 cells were pulsed with OVA peptide followed by co-culture with OT-I T cells at a 1:4 E/T ratio. Target cell death was analyzed by IncuCyte. Values are means ± SD of triplicate samples. ( D ) DKO B16 cells were pulsed with OVA peptide followed by co-culture with OT-I T cells at a 1:4 E/T ratio and treated with control IgG (50 μg/ml), anti-TNF (50 μg/ml), anti–IFN-γ (50 μg/ml), or both mAbs (50 μg/ml). Target cell death was analyzed by IncuCyte. Values are means ± SD of triplicate samples. ( E ) Tumor volume analysis of NSG mice bearing B16 WT- or DKO-cOVA tumors treated i.v. once on day 12 after tumor implant with PBS or OT-I T cells (1 x 10 6 cells in 100 μl); WT (PBS): n = 13 mice; DKO (PBS): n = 11 mice; WT (OT-I): n = 7 mice; DKO (OT-I): n = 8 mice. Values are means ± SEM. * P < 0.05 by unpaired t test. In (A) to (D), n = 3 technical replicates per group, and data are representative of at least three independent experiments.

Article Snippet: Antagonist antibodies used were from the following sources: TNF (clone XT3.11, Bio X Cell BE0058) and IFN-γ (clone XMG1.2, Bio X Cell BE0055).

Techniques: Control, Co-culture Assay, Analysis

( A ) WT, DKO, STAT1 single KO, and TBK1/IKKε/STAT1 TKO B16 cells were treated with IFN-γ (100 ng/ml) and analyzed by IncuCyte to measure cell death. Values are means ± SD of triplicate samples. ( B ) WT and DKO B16 cells were treated with IFN-γ (100 ng/ml) in the presence of DMSO or 1 μM ruxolitinib and analyzed by IncuCyte. Values are means ± SD of triplicate samples. ( C ) WT and DKO B16 cells were treated with IFN-γ (100 ng/ml) for the indicated times before RNA was isolated for sequencing. Values are displayed as log2 CPM comparing Tnfrsf1a expression. Data are from n = 3 biological replicates per group. Statistical analysis was performed by one-way ANOVA with Sidak’s multiple-comparison test; ns, not significant. ( D ) Western blotting analysis of the indicated proteins in WT and DKO B16 cells treated with IFN-γ (100 ng/ml) for the indicated times. Blot shown is representative of two experiments that were performed. Bar chart indicates signal intensity of TNFR1 relative to actin in each lane from the two experiments. ( E ) WT, DKO, and TBK1/IKKε/TNFR1 TKO B16 cells were treated with IFN-γ (100 ng/ml) (left) or pulsed with OVA peptide followed by co-culture with OT-I T cells at a 1:4 E/T ratio (right) and analyzed by IncuCyte. Values are means ± SD of triplicate samples. ( F ) WT, DKO, and TBK1/IKKε/TNF TKO B16 cells were treated with medium alone (left) or IFN-γ (100 ng/ml) (right) and analyzed by IncuCyte. Values are means ± SD of triplicate samples. ( G ) WT, DKO, TBK1/IKKε/TNFR1 TKO, TBK1/IKKε/TNF TKO cells, and DKO cells incubated with anti-TNF (50 μg/ml) were treated with IFN-γ (100 ng/ml) and analyzed by IncuCyte. Values are means ± SD of triplicate samples. In (A), (B), and (E) to (G), n = 3 technical replicates per group, and data are representative of at least three independent experiments.

Journal: Science signaling

Article Title: Loss of the kinases TBK1 and IKKε sensitizes target cancer cells to T cell killing through an IFN-γ–mediated inflammatory death program

doi: 10.1126/scisignal.adz7366

Figure Lengend Snippet: ( A ) WT, DKO, STAT1 single KO, and TBK1/IKKε/STAT1 TKO B16 cells were treated with IFN-γ (100 ng/ml) and analyzed by IncuCyte to measure cell death. Values are means ± SD of triplicate samples. ( B ) WT and DKO B16 cells were treated with IFN-γ (100 ng/ml) in the presence of DMSO or 1 μM ruxolitinib and analyzed by IncuCyte. Values are means ± SD of triplicate samples. ( C ) WT and DKO B16 cells were treated with IFN-γ (100 ng/ml) for the indicated times before RNA was isolated for sequencing. Values are displayed as log2 CPM comparing Tnfrsf1a expression. Data are from n = 3 biological replicates per group. Statistical analysis was performed by one-way ANOVA with Sidak’s multiple-comparison test; ns, not significant. ( D ) Western blotting analysis of the indicated proteins in WT and DKO B16 cells treated with IFN-γ (100 ng/ml) for the indicated times. Blot shown is representative of two experiments that were performed. Bar chart indicates signal intensity of TNFR1 relative to actin in each lane from the two experiments. ( E ) WT, DKO, and TBK1/IKKε/TNFR1 TKO B16 cells were treated with IFN-γ (100 ng/ml) (left) or pulsed with OVA peptide followed by co-culture with OT-I T cells at a 1:4 E/T ratio (right) and analyzed by IncuCyte. Values are means ± SD of triplicate samples. ( F ) WT, DKO, and TBK1/IKKε/TNF TKO B16 cells were treated with medium alone (left) or IFN-γ (100 ng/ml) (right) and analyzed by IncuCyte. Values are means ± SD of triplicate samples. ( G ) WT, DKO, TBK1/IKKε/TNFR1 TKO, TBK1/IKKε/TNF TKO cells, and DKO cells incubated with anti-TNF (50 μg/ml) were treated with IFN-γ (100 ng/ml) and analyzed by IncuCyte. Values are means ± SD of triplicate samples. In (A), (B), and (E) to (G), n = 3 technical replicates per group, and data are representative of at least three independent experiments.

Article Snippet: Antagonist antibodies used were from the following sources: TNF (clone XT3.11, Bio X Cell BE0058) and IFN-γ (clone XMG1.2, Bio X Cell BE0055).

Techniques: Isolation, Sequencing, Expressing, Analysis, Comparison, Western Blot, Co-culture Assay, Incubation

( A ) Western blotting analysis of the indicated proteins in WT and DKO B16 cells pretreated with 20 μM zVAD-fmk for 30 min, followed by IFN-γ (100 ng/ml) for the indicated times. Equal concentrations of lysates were then subjected to immunoprecipitation (IP) with antibody against ZBP1. Blot shown is representative of two experiments that were performed. Bar chart indicates signal intensity of RIPK1 relative to ZBP1 in each IP from the two experiments. ( B ) WT, DKO, TBK1/IKKε/TNFR1 TKO, TBK1/IKKε/ZBP1 TKO, and TBK1/IKKε/TNFR1/ZBP1 QKO B16 cells were treated with IFN-γ (100 ng/ml) for the indicated times and analyzed by IncuCyte. Values are means ± SD of triplicate samples. ( C ) Western blotting analysis of the indicated proteins in WT, DKO, TNFR1 TKO, ZBP1 TKO, and QKO B16 cells pretreated with 20 μM zVAD-fmk for 30 min, followed by IFN-γ (100 ng/ml) for 0 (−) or 24 (+) hours. Blot shown is representative of two that were performed. Bar chart indicates signal intensity of pRIPK1 relative to total RIPK1 in each lane from the two experiments. ( D ) Western blotting analysis of the indicated proteins in WT, DKO, TNFR1 TKO, ZBP1 TKO, and QKO B16 cells treated with the indicated concentrations of IFN-γ for 24 hours. The TNFR1 TKO and ZBP1 TKO are shown in two separate blots. Blots shown are representative of three that were performed. Bar chart indicates signal intensity of cleaved CASP8 and CASP3 relative to actin from the three experiments with each experiment coded in a different color. Values are means ± SD of the three biological replicates. ( E ) WT, DKO, TNFR1 TKO, ZBP1 TKO, and QKO B16 cells were pulsed with OVA peptide followed by co-culture with OT-I T cells at a 1:4 E/T ratio. Target cell death was analyzed by IncuCyte. Values are means ± SD of triplicate samples. In (B) and (E), n = 3 technical replicates per group, and data are representative of at least three independent experiments.

Journal: Science signaling

Article Title: Loss of the kinases TBK1 and IKKε sensitizes target cancer cells to T cell killing through an IFN-γ–mediated inflammatory death program

doi: 10.1126/scisignal.adz7366

Figure Lengend Snippet: ( A ) Western blotting analysis of the indicated proteins in WT and DKO B16 cells pretreated with 20 μM zVAD-fmk for 30 min, followed by IFN-γ (100 ng/ml) for the indicated times. Equal concentrations of lysates were then subjected to immunoprecipitation (IP) with antibody against ZBP1. Blot shown is representative of two experiments that were performed. Bar chart indicates signal intensity of RIPK1 relative to ZBP1 in each IP from the two experiments. ( B ) WT, DKO, TBK1/IKKε/TNFR1 TKO, TBK1/IKKε/ZBP1 TKO, and TBK1/IKKε/TNFR1/ZBP1 QKO B16 cells were treated with IFN-γ (100 ng/ml) for the indicated times and analyzed by IncuCyte. Values are means ± SD of triplicate samples. ( C ) Western blotting analysis of the indicated proteins in WT, DKO, TNFR1 TKO, ZBP1 TKO, and QKO B16 cells pretreated with 20 μM zVAD-fmk for 30 min, followed by IFN-γ (100 ng/ml) for 0 (−) or 24 (+) hours. Blot shown is representative of two that were performed. Bar chart indicates signal intensity of pRIPK1 relative to total RIPK1 in each lane from the two experiments. ( D ) Western blotting analysis of the indicated proteins in WT, DKO, TNFR1 TKO, ZBP1 TKO, and QKO B16 cells treated with the indicated concentrations of IFN-γ for 24 hours. The TNFR1 TKO and ZBP1 TKO are shown in two separate blots. Blots shown are representative of three that were performed. Bar chart indicates signal intensity of cleaved CASP8 and CASP3 relative to actin from the three experiments with each experiment coded in a different color. Values are means ± SD of the three biological replicates. ( E ) WT, DKO, TNFR1 TKO, ZBP1 TKO, and QKO B16 cells were pulsed with OVA peptide followed by co-culture with OT-I T cells at a 1:4 E/T ratio. Target cell death was analyzed by IncuCyte. Values are means ± SD of triplicate samples. In (B) and (E), n = 3 technical replicates per group, and data are representative of at least three independent experiments.

Article Snippet: Antagonist antibodies used were from the following sources: TNF (clone XT3.11, Bio X Cell BE0058) and IFN-γ (clone XMG1.2, Bio X Cell BE0055).

Techniques: Western Blot, Analysis, Immunoprecipitation, Co-culture Assay

( A ) Global transcriptomics analysis of enriched gene pathways measured as log 2 (fold change) between IFN-γ–stimulated vs. unstimulated control (Ctrl) WT cells (left), IFN-γ–stimulated vs. unstimulated control (Ctrl) DKO cells (middle), and a ratio of the IFN-γ–stimulated change in DKO cells vs. the IFN-γ–stimulated change in WT cells (right). ( B ) Heatmap expression profile of inflammatory genes obtained from the RNA-seq analysis of WT and DKO B16 cells stimulated with IFN-γ (100 ng/ml) for 0, 16, and 24 hours. ( C ) Global proteomics analysis of enriched proteins in pathways measured as log 2 (fold change) between IFN-γ–stimulated vs. unstimulated control (Ctrl) WT cells (left), IFN-γ–stimulated vs. unstimulated control (Ctrl) DKO cells (middle), and the ratio of the IFN-γ–stimulated change in DKO cells vs. the IFN-γ–stimulated change in WT cells (right). ( D ) Western blotting analysis of the indicated proteins in nuclear extracts obtained from WT, DKO, TNFR1 TKO, ZBP1 TKO, and QKO B16 cells treated with IFN-γ (100 ng/ml) for 0 or 24 hours. Blot shown is representative of two that were performed. ( E ) ELISA analysis of mouse CCL2 and CXCL9 in culture medium from WT, DKO, TNFR1 TKO, ZBP1 TKO, and QKO B16 cells treated with IFN-γ (100 ng/ml) for 0 or 24 hours. n = 3 biological replicates per group. ** P < 0.01 and **** P < 0.0001; ns, not significant. Statistical analysis was performed by unpaired t test. ( F ) Western blotting analysis of the indicated proteins in WT and DKO B16 cells treated with TNF (10 ng/ml) for the indicated times. Blot shown is representative of three that were performed. Bar chart indicates signal intensity of pIκBα relative to total IκBα in each lane from the three experiments, each coded in a different color. Values are means ± SD of the three biological replicates.

Journal: Science signaling

Article Title: Loss of the kinases TBK1 and IKKε sensitizes target cancer cells to T cell killing through an IFN-γ–mediated inflammatory death program

doi: 10.1126/scisignal.adz7366

Figure Lengend Snippet: ( A ) Global transcriptomics analysis of enriched gene pathways measured as log 2 (fold change) between IFN-γ–stimulated vs. unstimulated control (Ctrl) WT cells (left), IFN-γ–stimulated vs. unstimulated control (Ctrl) DKO cells (middle), and a ratio of the IFN-γ–stimulated change in DKO cells vs. the IFN-γ–stimulated change in WT cells (right). ( B ) Heatmap expression profile of inflammatory genes obtained from the RNA-seq analysis of WT and DKO B16 cells stimulated with IFN-γ (100 ng/ml) for 0, 16, and 24 hours. ( C ) Global proteomics analysis of enriched proteins in pathways measured as log 2 (fold change) between IFN-γ–stimulated vs. unstimulated control (Ctrl) WT cells (left), IFN-γ–stimulated vs. unstimulated control (Ctrl) DKO cells (middle), and the ratio of the IFN-γ–stimulated change in DKO cells vs. the IFN-γ–stimulated change in WT cells (right). ( D ) Western blotting analysis of the indicated proteins in nuclear extracts obtained from WT, DKO, TNFR1 TKO, ZBP1 TKO, and QKO B16 cells treated with IFN-γ (100 ng/ml) for 0 or 24 hours. Blot shown is representative of two that were performed. ( E ) ELISA analysis of mouse CCL2 and CXCL9 in culture medium from WT, DKO, TNFR1 TKO, ZBP1 TKO, and QKO B16 cells treated with IFN-γ (100 ng/ml) for 0 or 24 hours. n = 3 biological replicates per group. ** P < 0.01 and **** P < 0.0001; ns, not significant. Statistical analysis was performed by unpaired t test. ( F ) Western blotting analysis of the indicated proteins in WT and DKO B16 cells treated with TNF (10 ng/ml) for the indicated times. Blot shown is representative of three that were performed. Bar chart indicates signal intensity of pIκBα relative to total IκBα in each lane from the three experiments, each coded in a different color. Values are means ± SD of the three biological replicates.

Article Snippet: Antagonist antibodies used were from the following sources: TNF (clone XT3.11, Bio X Cell BE0058) and IFN-γ (clone XMG1.2, Bio X Cell BE0055).

Techniques: Gene Expression, Transcriptomics, Analysis, Control, Expressing, RNA Sequencing, Western Blot, Enzyme-linked Immunosorbent Assay

Schematic of how multiple responses downstream of cell stimulation by IFN-γ through its receptor IFNGR are regulated by TBK1 and IKKε. Left: In addition to their function in inducing type I IFN expression, TBK1 and IKKε suppress RIPK1-dependent cell death and IKKα/β-dependent NF-κB transcriptional activity. Right: In the absence of TBK1 and IKKε, IFN-γ induces RIPK1-dependent apoptosis and NF-κB–dependent inflammatory gene expression, which is driven by autocrine activation of TNFR1. ZBP1 also plays a secondary role in cell death that is redundant with that of TNFR1. The figure was created using BioRender.

Journal: Science signaling

Article Title: Loss of the kinases TBK1 and IKKε sensitizes target cancer cells to T cell killing through an IFN-γ–mediated inflammatory death program

doi: 10.1126/scisignal.adz7366

Figure Lengend Snippet: Schematic of how multiple responses downstream of cell stimulation by IFN-γ through its receptor IFNGR are regulated by TBK1 and IKKε. Left: In addition to their function in inducing type I IFN expression, TBK1 and IKKε suppress RIPK1-dependent cell death and IKKα/β-dependent NF-κB transcriptional activity. Right: In the absence of TBK1 and IKKε, IFN-γ induces RIPK1-dependent apoptosis and NF-κB–dependent inflammatory gene expression, which is driven by autocrine activation of TNFR1. ZBP1 also plays a secondary role in cell death that is redundant with that of TNFR1. The figure was created using BioRender.

Article Snippet: Antagonist antibodies used were from the following sources: TNF (clone XT3.11, Bio X Cell BE0058) and IFN-γ (clone XMG1.2, Bio X Cell BE0055).

Techniques: Cell Stimulation, Expressing, Activity Assay, Gene Expression, Activation Assay